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MANY WORKERS have shownthat human
breast cancers which contain oestrogen
receptors (RE) are more likely to respond
to hormonal therapy than those which do
not (McGuire et al., 1978). RE status, as
determined by conventional techniques is
a relatively poor indicator of responsive-
ness to hormonal therapies; only 35-63%
of patients classified as RE+ respond to
endocrine ablation (Roberts et al., 1978;
McGuire et al., 1978). Standard RE assay
techniquesrequire up to 300 mg oftumour,
an amount which is often unavailable in
cases presenting early with small primary
tumours, or where metastatic deposits are
inaccessible to open biopsy (e.g. in bone or
liver).
These limitations reduce the clinical
usefulness of RE assays and have led to a
search for alternative indicators of hor-
mone responsiveness which might dis-
criminate better and be detected in smaller
tumour samples. Progestogen receptor
(RP) (McGuire etal., 1978) andendogenous
peroxidase (Lyttle & De Sombre, 1977;
Duffy & Duffy, 1977; De Sombre et al.,
1975) are two proteins which have been
suggested as potential indicators of hor-
mone responsiveness.
The present study was set up to assess
the value of endogenous peroxidase as an
indicator of hormone dependence by
measuring peroxidase levels in rat maum-
mary tumours which serve as models of
hormone-dependent and -independent
growth.
DMBA-induced rat mammary tumours
are considered to serve as models ofovary-
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dependent growth. Previous work in our
department has shown that over 80% of
such tumours regress after oophorectomy
(Hawkins et al., 1978; Scott et al., 1979).
Twenty-four such tumours were examined
in this study. Two transplantable lines
(TG3 and TG5) of rat mammary tumour
which exhibit ovary-independent growth
(Hawkins et al., 1978) have been generated
in our department and 20 tumours ofthese
lines were also examined.
Each of the 44 tumours was dissected
free from the host animal, after ex-
sanguination. The tumour was then homo-
genized in an ice-cooled tube, at a con-
centration of 300 mg/ml in cold 10mM
Tris buffer (pH 8.0) with 10% glycerol
(v/v) using a Silverson homogenizer. The
homogenates were centrifuged for 45 min
at 39,000 g to yield a clear cytosol. A
random sample of 12 cytosols from each
group of tumours was then processed by
mixing each with 100 pi of monothiogly-
cerol and assaying for RE and RP by
saturation analysistechniques as described
elsewhere (Hawkins et al., 1977, and in
preparation). The cytosols from the other
tumours were discarded.
Each centrifugation pellet was then
homogenized at 300 mg/ml in 10mAt Tris
buffer (pH 7.4) containing 0-5AI calcium
chloride to solubilize any peroxidase pre-
sent. The homogenate was centrifuged for
45 min at 39,000 g to yield a clear cytosol
containing the solubilized peroxidase.
This extraction procedure is based on that
of De Sombre & Lyttle (1978).
The cytosol was then assayed for per-ENDOGENOUS PEROXIDASE IN BREAST CANCER
oxidase by a method based on that of
Himmelhoch et al. (1969). The reaction
mixture in the cuvette comprised 13mM
guaiacol, 0 4mM hydrogen peroxide and
10mM Tris buffer (pH 7.4) containing
0-5mM calcium chloride, in a final volume
of 3 ml. The reaction was started by
addition of cytosol, a volume between
0-1 and 0 5 ml being required to give a
suitable deflection of the spectrophoto-
meter needle. The rate of reaction was
measured by the change in absorbance at
470 nm between 1 and 3 min after starting
the reaction.
Receptor concentrations were expressed
in fmol/mg of wet tumour and peroxidase
content in u/g wet tumour. One peroxidase
unit was defined as the amount of enzyme
required to produce an increase of one
absorbance unit per minute under the
assay conditions used.
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FIG. 1. Endogenous peroxidase content in
rat mammary tumours which serve as
models for hormone-dependent and inde-
pendent growth. Each symbol represents
one tumour.
The Wilcoxon rank-sum test was used
to evaluate the differences between "hor-
mone dependent" and "hormone-inde-
pendent" tumours for concentrations of
each "indicator-protein".
Fig. 1 shows the endogenous peroxidase
content of each of the 24 DMBA-induced
tumours and each ofthe 20 transplantable
tumours. Peroxidase was detectable in all
but 2 of the DMBA-induced tumours, but
was undetectable in 6 of the transplant-
able tumours. Analysis of the levels in the
two groups revealed a highly significant
difference (P < 0001). Nevertheless there
is a considerable overlap in peroxidase
levels between the "hormone-dependent"
and "independent" tumour models.
Figs. 2 and 3 show the levels of RE and
RP in a random sample of 12 tumours
from each group. Significant differences
were again found between "hormone-
dependent" and "independent" tumours.
In the case of RE there was no overlap
between the groups. RP was undetectable
in one DMBA-induced tumour, but other-
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FIG. 2.-Oestrogen receptor content in rat
mammary tumours which serve as models
for hormone-dependent and independent
growth. Each symbolrepresents onetumour.
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FIG. 3.-Progestogen receptor content in rat
mammary tumours which serve as models
for hormone-dependent and independent
growth. Each symbol represents one
tumour.
wise the range of levels in the two groups
was quite distinct.
The results obtained in this study indi-
cate that RE and RP assays clearly dis-
criminate between hormone dependence
and independence in these rat mammary
tumours. It is known that not all DMBA-
induced tumours are hormone-dependent
and it might be postulated that the one
such tumour in which no RP could be
detected might have belonged to the
hormone-independent minority ofDMBA-
induced tumours. This study revealed no
overlap in RE levels between the two
groups but it should be noted that in
earlier generations of the TG3 and TG5
lines higher RE concentrations werefound,
andthe distinctionbetweenthegroups was
less clear-cut (Hawkins et al., 1978; Scott
et al., 1979).
Our results support the postulated rela-
tionship between peroxidase content and
hormone dependence. However, the over-
lap in peroxidase levels between the
largely hormone-dependent, DMBA-in-
ducedgroup andthehormone-independent
transplantable group was considerable.
It seems unlikely, therefore, that endo-
genous peroxidase will prove to be a more
reliable discriminator than RE.
Our findings are somewhat at variance
with those of Lyttle and his co-workers
(1979) in their studies of peroxidase levels
in mouse mammary-tumour models. They
found no overlap between hormone-
dependent and independent groups.
Peroxidase can be readily identified by
a simple histochemical technique (De
Sombre et al., 1975) and could, therefore,
be detected in much smaller biopsy speci-
mens than are needed for standard RE
assays. Peroxidase estimations in breast
tumours might, therefore, prove clinically
useful in overcoming one ofthe limitations
of standard receptor assays-namely, the
amount of tumour needed. However, the
findings of this study suggest that per-
oxidase is unlikely to provide a more
accurate prediction of hormone-respon-
siveness than RE.
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